Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 371,500
-500 (-0.13%)
Last updated: Jul 21, 2026, 2:05 PM KST
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩624,615. The average 1-year stock price forecast is 68.13% higher than the current stock price, while the lowest is ₩510,000 (+37.28%) and the highest is ₩740,000 (+99.19%).
Price Target: ₩624,615 (+68.13%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 7 | 6 | 5 | 5 |
| Buy | 8 | 8 | 8 | 8 | 7 | 7 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 15 | 13 | 13 |
Financial Forecast
Revenue This Year
1.32T
from 1.55T
Decreased by -14.79%
Revenue Next Year
1.77T
from 1.32T
Increased by 34.36%
EPS This Year
16.39K
from 13.36K
Increased by 22.64%
EPS Next Year
17.43K
from 16.39K
Increased by 6.39%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.